- DRMA Dashboard
- Financials
- Filings
- ETFs
- Insider
- Institutional
- Shorts
- News
-
ARS Filing
Dermata Therapeutics (DRMA) ARS2022 FY Annual report to shareholders
Filed: 23 Jun 23, 4:30pm
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.